Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Can bioprostheses be implanted at younger ages?].

J P Maroni1, J M Montely, M Terdjman

  • 1Centre hospitalier général Robert-Ballanger, 93602 Aulnay-Sous-Bois, France.

Annales De Cardiologie Et D'Angeiologie
|December 18, 2004
PubMed
Summary

Choosing between mechanical prosthesis (MP) and bioprosthesis (BP) for heart valves involves balancing longevity against risks. Current guidelines suggest MP for younger patients and BP for older ones, with a gray area in between.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The white book of the National College of Hospital Cardiologists (NCHC) -- to respond to a public health issue].

Annales de cardiologie et d'angeiologie·2012
Same author

[Very late intrastent thrombosis--at 27 months!].

Archives des maladies du coeur et des vaisseaux·2007
Same author

[Operative risk of heart valve surgery after 80 years].

Annales de cardiologie et d'angeiologie·2006
Same author

Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry.

Heart (British Cardiac Society)·2006
Same author

High risk hypertensives: pre-hospital management of acute myocardial infarction--results from the French nationwide registry USIC 2000.

Annales de cardiologie et d'angeiologie·2006
Same author

[Management of patients admitted for acute myocardial infarction in France from 1995 to 2000: time to admission dependent improvement in outcome].

Archives des maladies du coeur et des vaisseaux·2005

Area of Science:

  • Cardiovascular Surgery
  • Biomaterials Science
  • Medical Device Technology

Context:

  • Heart valve replacement surgery involves selecting between mechanical prostheses (MP) and bioprostheses (BP).
  • Each prosthesis type presents distinct advantages and disadvantages regarding durability, thromboembolic risk, and need for anticoagulation.
  • Patient age and specific valve location (aortic vs. mitral) influence the optimal choice.

Purpose:

  • To delineate the decision-making process for selecting mechanical prostheses versus bioprostheses in heart valve replacement.
  • To analyze the trade-offs between long-term durability and thromboembolic risks associated with each prosthesis type.
  • To review current age-based recommendations and factors influencing the choice of prosthetic heart valves.

Summary:

Related Experiment Videos

  • Mechanical prostheses offer theoretical longevity but necessitate lifelong anticoagulation, increasing hemorrhage risk.
  • Bioprostheses have a lower thromboembolic risk but a limited lifespan, requiring future reoperation.
  • Current consensus favors mechanical prostheses before age 60 and bioprostheses after age 70, with nuanced guidelines for the 60-70 age range.

Impact:

  • Informs clinical decision-making for prosthetic heart valve selection, optimizing patient outcomes.
  • Highlights the dynamic nature of recommendations influenced by patient-specific factors and technological advancements.
  • Suggests potential future shifts in implantation limits for bioprostheses with ongoing innovation.